Health and budget impact, and price threshold for cost-effectiveness of lenacapavir for PrEP in Eastern and Southern Africa: a modeling analysis | medRxiv

Article usage

Article usage: August 2024 to June 2025

	Abstract	Full	Pdf
Aug 2024	188	7	47
Sep 2024	86	22	51
Oct 2024	71	123	28
Nov 2024	62	3	22
Dec 2024	101	38	33
Jan 2025	62	32	39
Feb 2025	51	44	17
Mar 2025	48	83	24
Apr 2025	53	167	37
May 2025	50	180	29
Jun 2025	14	24	3

View the discussion thread.

Posted August 21, 2024.

Supplementary Material

Subject Area

HIV/AIDS

Subject Areas

All Articles

Addiction Medicine (349)
Allergy and Immunology (668)
Allergy and Immunology (668)
Anesthesia (181)
Cardiovascular Medicine (2648)
Dentistry and Oral Medicine (316)
Dermatology (223)
Emergency Medicine (399)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
Epidemiology (12228)
Forensic Medicine (10)
Gastroenterology (759)
Genetic and Genomic Medicine (4103)
Geriatric Medicine (387)
Health Economics (680)
Health Informatics (2657)
Health Policy (1005)
Health Systems and Quality Improvement (985)
Hematology (363)
HIV/AIDS (851)
Infectious Diseases (except HIV/AIDS) (13695)
Intensive Care and Critical Care Medicine (797)
Medical Education (399)
Medical Ethics (109)
Nephrology (436)
Neurology (3882)
Nursing (209)
Nutrition (577)
Obstetrics and Gynecology (739)
Occupational and Environmental Health (695)
Oncology (2030)
Ophthalmology (585)
Orthopedics (240)
Otolaryngology (306)
Pain Medicine (250)
Palliative Medicine (75)
Pathology (473)
Pediatrics (1115)
Pharmacology and Therapeutics (466)
Primary Care Research (452)
Psychiatry and Clinical Psychology (3432)
Public and Global Health (6527)
Radiology and Imaging (1403)
Rehabilitation Medicine and Physical Therapy (814)
Respiratory Medicine (871)
Rheumatology (409)
Sexual and Reproductive Health (410)
Sports Medicine (342)
Surgery (448)
Toxicology (53)
Transplantation (185)
Urology (165)